Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CONSTELLIUM SE (CSTM)

  • SEC News
  • May 07, 2026, 14:02 UTC
  • 2
  • 1 comments

Guo Jack Q. 🔴 sold 25.2K shares of CONSTELLIUM SE (CSTM) at $32.62 Transaction Date: May 05, 2026 | Filing ID: 000002

Comment Full text

VELOCITY FINANCIAL, INC. (VEL)

  • SEC News
  • May 07, 2026, 14:01 UTC
  • 2
  • 1 comments

(99% Neutral) VELOCITY FINANCIAL, INC. (VEL) Announces Regulatory Update

Comment Full text

COTY INC. (COTY)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Coty Inc. Of Class Action Lawsuit and Upcoming Deadlines - COTY

Market reaction Comment Full text

STRYKER CORP (SYK)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corporation - SYK

Market reaction Comment Full text

POWER SOLUTIONS INTERNATIONAL, INC. (PSIX)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 2
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Power Solutions International, Inc. of Class Action Lawsuit and Upcoming Deadlines - PSIX

Market reaction Comment Full text

SPORTRADAR GROUP AG (SRAD)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 0
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sportradar Group AG - SRAD

Market reaction Comment Full text

GLOBANT S.A. (GLOB)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Globant SA of Class Action Lawsuit and Upcoming Deadlines - GLOB

Market reaction Comment Full text

ORIC PHARMACEUTICALS, INC. (ORIC)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC

Market reaction Comment Full text

JOURNEY MEDICAL CORP (DERM)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM

Market reaction Comment Full text

ROCKY BRANDS, INC. (RCKY)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 2
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocky Brands, Inc. - RCKY

Market reaction Comment Full text

CHECK POINT SOFTWARE TECHNOLOGIES LTD (CHKP)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Check Point Software Technologies Ltd. - CHKP

Market reaction Comment Full text

BADGER METER INC (BMI)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Badger Meter, Inc. - BMI

Market reaction Comment Full text

PINTEREST, INC. (PINS)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 3
  • 1 comments

Pomerantz Law Firm Announces the Filing of a Class Action Against Pinterest, Inc. and Certain Officers - PINS

Market reaction Comment Full text

IMMUNITYBIO, INC. (IBRX)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 3
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ImmunityBio, Inc. Of Class Action Lawsuit and Upcoming Deadlines - IBRX

Market reaction Comment Full text

MIMEDX GROUP, INC. (MDXG)

  • Business News
  • May 07, 2026, 14:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

Market reaction Comment Full text
  • Previous
  • 223
  • 224
  • 225
  • 226
  • 227
  • Next

Search

News categories

  • Technical Exchange News(12372)
  • Event(6229)
  • SEC News(272503)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158357)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin